Monitor for follow-up announcements regarding commercialization of the pilot, expansion of data usage, or additional partnerships. Absent revenue commitments, near-term financial impact is likely minimal despite strategic validation of OneMedNet’s platform.
Price Chart
Executive Summary
OneMedNet announced a pilot collaboration with Inka Health, a subsidiary of Onco-Innovations, granting access to its iRWD™ platform for real-world oncology data analysis. The partnership aims to accelerate development of Onco’s PNKP Inhibitor Technology by identifying rare patient populations and supporting indication expansion. While strategically aligned with OneMedNet’s platform goals, the deal lacks disclosed financial terms or revenue commitments.
Key Facts
- Inka Health (subsidiary of Onco-Innovations) entered a pilot collaboration with OneMedNet to access its iRWD™ platform.
- The collaboration focuses on using real-world data to support development of PNKP Inhibitor Technology for PTEN/SHP1-deficient cancers.
- Initial use cases include patient responder identification, indication expansion beyond metastatic colorectal cancer, and enhancing SynoGraph™, an AI platform for predicting cancer treatment success.
- The iRWD™ platform is powered by Palantir Foundry and designed to identify rare, molecularly defined patient cohorts.
- No financial terms, duration, or revenue commitments were disclosed in the press release.
Financial Impact
Unknown — no financial terms disclosed; potential future revenue depends on pilot conversion to commercial agreement
Risk Factors
- Pilot may not convert into a long-term or revenue-generating agreement.
- Dependence on third-party success (Onco-Innovations) for downstream value realization.
- Limited market visibility due to small partner size and lack of financial disclosure.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3266641 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 24, 2026 10w ago | 8-K | $0.6059 $0.5901 | ▼ −2.61% | ▼ −5.91% | $5.39 (+789.59%) |
Jul 13, 2026 11w ago | EFFECT | $0.7457 $0.6600 | ▼ −11.49% | ▼ −14.68% | $5.39 (+622.81%) |
Jun 17, 2026 15w ago | Insider Cluster | $0.6023 $0.6901 | ▲ +14.58% | ▲ +13.26% | $5.39 (+794.90%) |
Jun 16, 2026 15w ago | Insider Cluster | $0.5011 $0.7267 | ▲ +45.02% | ▲ +44.82% | $5.39 (+975.63%) |
Apr 6, 2026 25w ago | Press Release | $0.9520 $1.05 | ▲ +10.29% | ▲ +1.31% | $5.39 (+466.18%) |
Apr 1, 2026 26w ago | Press Release | $0.8440 $1.08 | ▲ +27.96% | ▲ +18.24% | $5.39 (+538.63%) |
Mar 18, 2026 28w ago | Press Release | $0.8190 $0.8870 | ▲ +8.30% | ▲ +2.26% | $5.39 (+558.12%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access